{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T21:56:24Z","timestamp":1761947784947,"version":"build-2065373602"},"reference-count":180,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.jfo.2011.10.002","type":"journal-article","created":{"date-parts":[[2012,2,14]],"date-time":"2012-02-14T07:19:34Z","timestamp":1329203974000},"page":"292-307","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Aspects actuels du traitement des k\u00e9ratites herp\u00e9tiques"],"prefix":"10.1016","volume":"35","author":[{"given":"M.","family":"Labetoulle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Colin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfo.2011.10.002_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00003226-200101000-00001","article-title":"Herpes simplex virus epidemiology and ocular importance","volume":"20","author":"Liesegang","year":"2001","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2011.10.002_bib0010","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1001\/archopht.1989.01070020221029","article-title":"Epidemiology of ocular herpes simplex. Incidence in Rochester, Minn, 1950\u00a0through 1982","volume":"107","author":"Liesegang","year":"1989","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0015","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s007050050533","article-title":"Evolution of herpes simplex virus type 1\u00a0under herpesviral evolutionary processes","volume":"144","author":"Umene","year":"1999","journal-title":"Arch Virol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0020","series-title":"Oeil et virus","first-page":"219","article-title":"Pathologies de la corn\u00e9e et de la conjonctive. Atteintes herp\u00e9tiques. Zona ophtalmique","author":"Colin","year":"2000"},{"key":"10.1016\/j.jfo.2011.10.002_bib0025","doi-asserted-by":"crossref","first-page":"14079","DOI":"10.1128\/JVI.79.22.14079-14087.2005","article-title":"Laser-capture microdissection\u00a0: refining estimates of the quantity and distribution of latent herpes simplex virus 1\u00a0and varicella-zoster virus DNA in human trigeminal Ganglia at the single-cell level","volume":"79","author":"Wang","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0030","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/0022-510X(93)90082-A","article-title":"Age distribution of latent herpes simplex virus 1\u00a0and varicella-zoster virus genome in human nervous tissue","volume":"116","author":"Liedtke","year":"1993","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jfo.2011.10.002_bib0035","series-title":"Fields Virology","first-page":"2461","article-title":"Herpes simplex viruses","author":"Whitley","year":"2001"},{"key":"10.1016\/j.jfo.2011.10.002_bib0040","doi-asserted-by":"crossref","first-page":"289","DOI":"10.4049\/jimmunol.104.2.289","article-title":"A prospective study of chronic herpes simplex virus infection and recurrent herpes labialis in humans","volume":"104","author":"Douglas","year":"1970","journal-title":"J Immunol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0045","doi-asserted-by":"crossref","first-page":"5601","DOI":"10.1167\/iovs.09-3729","article-title":"A double-blind placebo-controlled study to evaluate valacyclovir alone and with aspirin for asymptomatic HSV-1\u00a0DNA shedding in human tears and saliva","volume":"50","author":"Kumar","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2011.10.002_bib0050","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1097\/00003226-200310001-00008","article-title":"Quantitative analysis of herpes simplex virus genome in tears from patients with herpetic keratitis","volume":"22","author":"Fukuda","year":"2003","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2011.10.002_bib0055","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1136\/bjo.84.11.1238","article-title":"Detection of herpes simplex virus type 1, 2\u00a0and varicella zoster virus DNA in recipient corneal buttons","volume":"84","author":"van Gelderen","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0060","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/jmv.10454","article-title":"Herpes simplex virus DNA in corneal transplants: prospective study of 38\u00a0recipients","volume":"71","author":"Robert","year":"2003","journal-title":"J Med Virol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0065","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/ICO.0b013e3181ef241d","article-title":"Ocular herpes simplex virus type 1: is the cornea a reservoir for viral latency or a fast pit stop?","volume":"30","author":"Kennedy","year":"2011","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2011.10.002_bib0070","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/0039-6257(91)90127-2","article-title":"Herpes simplex virus: molecular biology and the possibility of corneal latency","volume":"36","author":"Cook","year":"1991","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0075","doi-asserted-by":"crossref","DOI":"10.1097\/ICO.0b013e3181d3d69d","article-title":"The quantitative detection of herpes simplex virus, varicella zoster virus, and cytomegalovirus DNAs in recipient corneal buttons","author":"Kaneko","year":"2010","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2011.10.002_bib0080","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1167\/iovs.02-0464","article-title":"HSV1\u00a0latency sites after inoculation in the lip: assessment of their localization and connections to the eye","volume":"44","author":"Labetoulle","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2011.10.002_bib0085","doi-asserted-by":"crossref","first-page":"4142","DOI":"10.1128\/jvi.65.8.4142-4152.1991","article-title":"Induction of cellular transcription factors in trigeminal ganglia of mice by corneal scarification, herpes simplex type 1\u00a0infection, and explantation of trigeminal ganglia","volume":"65","author":"Valyi-Nagy","year":"1991","journal-title":"J Virol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0090","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1001\/archophthalmol.2010.187","article-title":"Incidence, recurrence, and outcomes of herpes simplex virus eye disease in Olmsted County, Minnesota, 1976-2007: the effect of oral antiviral prophylaxis","volume":"128","author":"Young","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0095","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.ophtha.2004.11.052","article-title":"Incidence of herpes keratitis in France","volume":"112","author":"Labetoulle","year":"2005","journal-title":"Ophtalmology"},{"key":"10.1016\/j.jfo.2011.10.002_bib0100","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/ng1097","article-title":"Impaired response to interferon-alpha\/beta and lethal viral disease in human STAT1\u00a0deficiency","volume":"33","author":"Dupuis","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.jfo.2011.10.002_bib0105","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1086\/590213","article-title":"Susceptibility to herpes simplex labialis conferred by the gene encoding apolipoprotein E","volume":"198","author":"Itzhaki","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jfo.2011.10.002_bib0110","first-page":"425","article-title":"Mod\u00e8les animaux d\u2019infection \u00e0 HSV1\u00a0: des outils pour mieux comprendre le neurotropisme et la latence herp\u00e9tique","volume":"7","author":"Labetoulle","year":"2004","journal-title":"Virologie"},{"key":"10.1016\/j.jfo.2011.10.002_bib0115","series-title":"L\u2019herp\u00e8s et le zona oculaire en pratique\u00a0: clinique, th\u00e9rapeutique et pr\u00e9vention","first-page":"51","article-title":"\u00c9pid\u00e9miologie de la maladie herp\u00e9tique oculaire","author":"Labetoulle","year":"2009"},{"key":"10.1016\/j.jfo.2011.10.002_bib0120","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/jmv.10466","article-title":"Genotyping of herpes simplex virus type 1\u00a0strains isolated from ocular materials of patients with herpetic keratitis","volume":"71","author":"Umene","year":"2003","journal-title":"J Med Virol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0125","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1001\/archopht.1989.01070020226030","article-title":"Epidemiology of ocular herpes simplex. Natural history in Rochester, Minn, 1950\u00a0through 1982","volume":"107","author":"Liesegang","year":"1989","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0130","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1001\/archopht.1981.03930020452009","article-title":"Prognosis indicators of herpetic keratitis. Analysis of a five-year observation period after corneal ulceration","volume":"99","author":"Wilhelmus","year":"1981","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0135","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1755-3768.1970.tb06577.x","article-title":"Dendritic (herpetic) keratitis. I. Incidence--seasonal variations--recurrence rate--visual impairment\u00a0\u2013\u00a0therapy","volume":"48","author":"Norn","year":"1970","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"10.1016\/j.jfo.2011.10.002_bib0140","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000307814","article-title":"The incidence of herpetic keratitis among population","volume":"173","author":"Ribaric","year":"1976","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.jfo.2011.10.002_bib0145","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/0002-9394(81)90285-3","article-title":"Statistical analysis of the rate of recurrence of herpesvirus ocular epithelial disease","volume":"91","author":"Shuster","year":"1981","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0150","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/bjo.69.1.2","article-title":"Epidemiological and clinical features of primary herpes simplex virus ocular infection","volume":"69","author":"Darougar","year":"1985","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0155","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1136\/bjo.71.9.669","article-title":"Recurrent herpes simplex virus ocular infection: epidemiological and clinical features","volume":"71","author":"Wishart","year":"1987","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0160","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1056\/NEJM199807303390503","article-title":"Acyclovir for the prevention of recurrent herpes simplex virus eye disease","volume":"339","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfo.2011.10.002_bib0165","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1001\/archopht.118.12.1617","article-title":"Psychological stress and other potential triggers for recurrences of herpes simplex virus eye infections","volume":"118","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0170","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.ajo.2006.06.050","article-title":"Atopic disease and herpes simplex eye disease: a population-based case-control study","volume":"142","author":"Prabriputaloong","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0175","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.ajo.2006.01.072","article-title":"Comparative study of ocular herpes simplex virus in patients with and without self-reported atopy","volume":"141","author":"Rezende","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0180","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1016\/j.ophtha.2005.07.014","article-title":"Herpetic eye disease in diabetic patients","volume":"112","author":"Kaiserman","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2011.10.002_bib0185","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/ICO.0b013e318041f0c0","article-title":"Herpes simplex keratitis after intravitreal triamcinolone acetonide","volume":"26","author":"Shtein","year":"2007","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2011.10.002_bib0190","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1097\/ICO.0b013e3180cab659","article-title":"A case of herpetic keratitis after intravitreal triamcinolone injection","volume":"26","author":"Gulkilik","year":"2007","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2011.10.002_bib0195","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/ICO.0b013e31818a7d9a","article-title":"A case of herpetic epithelial keratitis after triamcinolone acetonide subtenon injection","volume":"28","author":"Hashizume","year":"2009","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2011.10.002_bib0200","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1136\/bjo.78.6.458","article-title":"Herpes simplex keratitis in children","volume":"78","author":"Beigi","year":"1994","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0205","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3928\/0191-3913-19870301-10","article-title":"Herpes simplex keratitis and amblyopia","volume":"24","author":"Beneish","year":"1987","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"10.1016\/j.jfo.2011.10.002_bib0210","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ajo.2004.04.027","article-title":"Herpes simplex virus keratitis in children","volume":"138","author":"Chong","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000309177","article-title":"L\u2019herp\u00e8s oculaire de l\u2019enfant","volume":"184","author":"Colin","year":"1982","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.jfo.2011.10.002_bib0220","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1001\/archopht.1980.01020030698009","article-title":"Herpetic ocular infections of childhood","volume":"98","author":"Poirier","year":"1980","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0225","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0161-6420(99)00052-4","article-title":"Oral acyclovir for the management of herpes simplex virus keratitis in children","volume":"107","author":"Schwartz","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2011.10.002_bib0230","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1006\/exer.2000.0886","article-title":"Acyclovir-resistant bilateral keratitis associated with mutations in the HSV-1\u00a0thymidine kinase gene","volume":"71","author":"Bodaghi","year":"2000","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jfo.2011.10.002_bib0235","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0161-6420(97)30351-0","article-title":"Herpes simplex virus keratitis among patients who are positive or negative for human immunodeficiency virus: an epidemiologic study","volume":"104","author":"Hodge","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2011.10.002_bib0240","first-page":"516","article-title":"Indications des k\u00e9ratoplasties transfixiantes. \u00c9tude r\u00e9trospective de 2962\u00a0cas sur 11\u00a0ans","volume":"16","author":"Legeais","year":"1993","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0245","first-page":"6","article-title":"Histologic findings in a series of 1,540\u00a0corneal allografts","volume":"21","author":"Leger","year":"2001","journal-title":"Ann Pathol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0250","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/eye.1993.106","article-title":"Changing indications for penetrating keratoplasty, 197\u20131990","volume":"7","author":"Sharif","year":"1993","journal-title":"Eye"},{"key":"10.1016\/j.jfo.2011.10.002_bib0255","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ajo.2003.09.057","article-title":"New onset of herpes simplex virus epithelial keratitis after penetrating keratoplasty","volume":"137","author":"Rezende","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0260","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00003226-200103000-00016","article-title":"Primary graft failure caused by herpes simplex virus type 1","volume":"20","author":"De Kesel","year":"2001","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2011.10.002_bib0265","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1600-0420.1995.tb00008.x","article-title":"Recurrence and rejection rates following corneal transplantation for herpes simplex keratitis","volume":"73","author":"Lomholt","year":"1995","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.jfo.2011.10.002_bib0270","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S0161-6420(97)30257-7","article-title":"Newly acquired herpes simplex virus keratitis after penetrating keratoplasty","volume":"104","author":"Remeijer","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2011.10.002_bib0275","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1001\/archopht.1997.01100150588001","article-title":"Herpes simplex virus in primary graft failure","volume":"115","author":"Cockerham","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0280","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1136\/bjo.84.7.701","article-title":"Graft failure in human donor corneas due to transmission of herpes simplex virus","volume":"84","author":"Biswas","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0285","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/01.TP.0000102458.30516.13","article-title":"Ultrastructural demonstration of replicative herpes simplex virus type 1\u00a0transmission through corneal graft","volume":"77","author":"Thuret","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.jfo.2011.10.002_bib0290","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1055\/s-2005-858849","article-title":"How \u201csafe\u201d is corneal transplantation? A contribution on the risk of HSV-transmission due to corneal transplantation","volume":"222","author":"Robert","year":"2005","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"10.1016\/j.jfo.2011.10.002_bib0295","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0181-5512(06)73781-0","article-title":"Surveillance s\u00e9rologique pour les Herpesvirus chez les receveurs de greffe de corn\u00e9e","volume":"29","author":"Robert","year":"2006","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0300","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1136\/bjo.80.7.654","article-title":"Detection of herpes simplex virus DNA in donor cornea culture medium by polymerase chain reaction","volume":"80","author":"Morris","year":"1996","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0305","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3928\/1081-597X-20050701-17","article-title":"Herpes simplex virus keratitis after laser in situ keratomileusis","volume":"21","author":"Levy","year":"2005","journal-title":"J Refract Surg"},{"key":"10.1016\/j.jfo.2011.10.002_bib0310","first-page":"139","article-title":"Herpes simplex keratitis following laser in situ keratomileusis","volume":"79","author":"Gomez","year":"2004","journal-title":"Arch Soc Esp Oftalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0315","first-page":"69","article-title":"Herpes simplex reactivation following laser in situ keratomileusis and subsequent corneal perforation","volume":"28","author":"Perry","year":"2002","journal-title":"CLAO J"},{"key":"10.1016\/j.jfo.2011.10.002_bib0320","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3928\/1081-597X-19981101-18","article-title":"Herpes simplex keratitis after LASIK","volume":"14","author":"Davidorf","year":"1998","journal-title":"J Refract Surg"},{"key":"10.1016\/j.jfo.2011.10.002_bib0325","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jcrs.2006.11.005","article-title":"Infectious and noninfectious keratitis after laser in situ keratomileusis. Occurrence, management, and visual outcomes","volume":"33","author":"Moshirfar","year":"2007","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.jfo.2011.10.002_bib0330","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0002-9394(00)00589-4","article-title":"Presumed activation of herpetic keratouveitis after Argon laser peripheral iridotomy","volume":"130","author":"Gaynor","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0335","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/01.ico.0000114123.63670.13","article-title":"Recurrent herpetic keratouveitis following YAG laser peripheral iridotomy","volume":"23","author":"Hou","year":"2004","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2011.10.002_bib0340","first-page":"640","article-title":"Herpes simplex keratitis following argon laser trabeculoplasty","volume":"25","author":"Reed","year":"1994","journal-title":"Ophthalmic Surg"},{"key":"10.1016\/j.jfo.2011.10.002_bib0345","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/ICO.0b013e318033a708","article-title":"Herpes simplex keratitis after cataract surgery","volume":"26","author":"Barequet","year":"2007","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2011.10.002_bib0350","first-page":"538","article-title":"Herpes simplex keratitis after ophthalmic surgery","volume":"107","author":"Miyajima","year":"2003","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"10.1016\/j.jfo.2011.10.002_bib0355","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/j.survophthal.2008.08.004","article-title":"Side effects associated with prostaglandin analog therapy","volume":"53","author":"Alm","year":"2008","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0360","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1136\/bjo.2007.131037","article-title":"Use of ocular hypotensive prostaglandin analogues in patients with uveitis: does their use increase anterior uveitis and cystoid macular oedema?","volume":"92","author":"Chang","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0365","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ajo.2009.02.032","article-title":"Outcome of raised intraocular pressure in uveitic eyes with and without a corticosteroid-induced hypertensive response","volume":"148","author":"Sallam","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0370","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00417-009-1036-3","article-title":"Efficacy and safety of latanoprost in eyes with uveitic glaucoma","volume":"247","author":"Markomichelakis","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0375","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4103\/0301-4738.21610","article-title":"Herpes simplex keratitis and visual impairment: a case series","volume":"54","author":"Kabra","year":"2006","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0380","first-page":"CD002898","article-title":"Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis","author":"Wilhelmus","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jfo.2011.10.002_bib0385","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1136\/bjo.2006.098830","article-title":"Effects of topical anaesthetics and fluorescein on the real-time PCR used for the diagnosis of Herpesviruses and Acanthamoeba keratitis","volume":"90","author":"Goldschmidt","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0390","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.ajo.2005.10.056","article-title":"Rose bengal and lissamine green inhibit detection of herpes simplex virus by PCR","volume":"141","author":"Seitzman","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0395","first-page":"87","article-title":"Reflex and steady state tears in patients with latent stromal herpetic keratitis","volume":"43","author":"Keijser","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2011.10.002_bib0400","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1001\/archophthalmol.2009.163","article-title":"Modalities to decrease stromal herpes simplex keratitis reactivation rates","volume":"127","author":"Sheppard","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0405","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1097\/ICO.0b013e3181cbf9f5","article-title":"Association between unilateral quiescent stromal herpetic keratitis and bilateral dry eyes","volume":"29","author":"Simard-Lebrun","year":"2010","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2011.10.002_bib0410","doi-asserted-by":"crossref","first-page":"4516","DOI":"10.1167\/iovs.10-5225","article-title":"Selective changes in human corneal sensation associated with herpes simplex virus keratitis","volume":"51","author":"Gallar","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2011.10.002_bib0415","series-title":"L\u2019herp\u00e8s et le zona oculaire en pratique\u00a0: clinique, th\u00e9rapeutique et pr\u00e9vention","first-page":"125","article-title":"K\u00e9ratites m\u00e9taherp\u00e9tiques","author":"Bourcier","year":"2009"},{"key":"10.1016\/j.jfo.2011.10.002_bib0420","series-title":"Oeil et virus","first-page":"85","article-title":"Traitement des infections virales","author":"Agut","year":"2000"},{"key":"10.1016\/j.jfo.2011.10.002_bib0425","series-title":"L\u2019herp\u00e8s et le zona oculaire en pratique\u00a0: clinique, th\u00e9rapeutique et pr\u00e9vention","first-page":"105","article-title":"Traitement des k\u00e9ratites herp\u00e9tiques (formes m\u00e9taherp\u00e9tiques exclues)","author":"Labetoulle","year":"2009"},{"key":"10.1016\/j.jfo.2011.10.002_bib0430","first-page":"CD002898","article-title":"Therapeutic interventions for herpes simplex virus epithelial keratitis","author":"Wilhelmus","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jfo.2011.10.002_bib0435","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1136\/bjo.63.6.418","article-title":"Treatement of amoeboid herpetic ulcers with adenine arabinoside or trifluorothymidine","volume":"63","author":"Coster","year":"1979","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0440","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1001\/archopht.1982.01030040944016","article-title":"Intraocular antiviral penetration","volume":"100","author":"Poirier","year":"1982","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0445","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/00003226-200009000-00012","article-title":"The evolution of antiviral therapy for external ocular viral infections over twenty-five years","volume":"19","author":"Gordon","year":"2000","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2011.10.002_bib0450","first-page":"505","article-title":"The treatment of herpes simplex virus epithelial keratitis","volume":"98","author":"Wilhelmus","year":"2000","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.jfo.2011.10.002_bib0455","first-page":"2969","article-title":"K\u00e9ratite herp\u00e9tique superficielle. Traitement comparatif en double insu par aciclovir et idoxuridine","volume":"10","author":"Colin","year":"1981","journal-title":"Nouv Presse Med"},{"key":"10.1016\/j.jfo.2011.10.002_bib0460","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1136\/bjo.64.10.766","article-title":"Randomised double-blind trial of acyclovir and idoxuridine in dendritic corneal ulceration","volume":"64","author":"Collum","year":"1980","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0465","first-page":"25","article-title":"Double-blind treatment of ocular herpes simplex: Vira-A and acyclovir","volume":"83","author":"Denis","year":"1983","journal-title":"Bull Soc Ophtalmol Fr"},{"key":"10.1016\/j.jfo.2011.10.002_bib0470","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/00003226-199707000-00004","article-title":"Ganciclovir ophthalmic gel (Virgan\u00a0; 0.15\u00a0%) in the treatment of herpes simplex keratitis","volume":"16","author":"Colin","year":"1997","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2011.10.002_bib0475","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1136\/bjo.80.2.140","article-title":"Randomised trial of ganciclovir and acyclovir in the treatment of herpes simplex dendritic keratitis: a multicentre study","volume":"80","author":"Hoh","year":"1996","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0480","doi-asserted-by":"crossref","first-page":"905","DOI":"10.2147\/OPTH.S8666","article-title":"Topical ganciclovir in the treatment of acute herpetic keratitis","volume":"4","author":"Tabbara","year":"2010","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0485","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2165\/11207240-000000000-00000","article-title":"Ganciclovir ophthalmic gel 0.15\u00a0%: in acute herpetic keratitis (dendritic ulcers)","volume":"71","author":"Croxtall","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.jfo.2011.10.002_bib0490","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1089\/jop.1994.10.439","article-title":"Ganciclovir ophthalmic gel in herpes simplex virus rabbit keratitis: intraocular penetration and efficacy","volume":"10","author":"Castela","year":"1994","journal-title":"J Ocul Pharmacol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0495","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1001\/archopht.116.6.777","article-title":"Trifluridine, cidofovir, and penciclovir in the treatment of experimental herpetic keratitis","volume":"116","author":"Kaufman","year":"1998","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0500","first-page":"256","article-title":"Efficacy of four antiviral agents in the treatment of uncomplicated herpetic keratitis","volume":"30","author":"Panda","year":"1995","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0505","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3109\/02713689109020379","article-title":"Bromovinyldeoxyuridine treatment of herpetic keratitis clinically resistant to other antiviral agents","volume":"10","author":"Maudgal","year":"1991","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.jfo.2011.10.002_bib0510","first-page":"378","article-title":"Comparative antiviral efficacies of cidofovir, trifluridine, and acyclovir in the HSV-1\u00a0rabbit keratitis model","volume":"40","author":"Romanowski","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2011.10.002_bib0515","series-title":"Infections et infections du segment ant\u00e9rieur de l\u2019\u0153il","first-page":"195","article-title":"Les k\u00e9ratites","author":"Adenis","year":"1989"},{"key":"10.1016\/j.jfo.2011.10.002_bib0520","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/00003226-199505000-00017","article-title":"Topical interferon alpha-2a treatment of herpes simplex keratitis resistant to multiple antiviral medications in an immunosuppressed patient","volume":"14","author":"Minkovitz","year":"1995","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2011.10.002_bib0525","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0002-9394(14)78303-5","article-title":"Combination therapy for dendritic keratitis with human leukocyte interferon and acyclovir","volume":"95","author":"Colin","year":"1983","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0530","series-title":"Herpes et zona oculaire: de la clinique au traitement","first-page":"31","article-title":"Alphaherpesvirinae II: virus varicelle-zona et mode d\u2019action des antiviraux","author":"Deback","year":"2009"},{"key":"10.1016\/j.jfo.2011.10.002_bib0535","unstructured":"Harding SP, Rigal D, Sharma MS, Natha S, Sarapa N, Weller S. Superior intraocular penetration of aciclovir after valaciclovir in comparison with oral aciclovir. 38th Interdisciplinary Conference on Antimicrobial Chemotherapy. San Diego (USA), October 1998, Abstract A-45."},{"key":"10.1016\/j.jfo.2011.10.002_bib0540","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/clpt.1993.196","article-title":"Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single- and multiple-dose administration to normal volunteers","volume":"54","author":"Weller","year":"1993","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jfo.2011.10.002_bib0545","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0090-9556(25)08306-0","article-title":"Metabolic fate and pharmacokinetics of the acyclovir prodrug valaciclovir in cynomolgus monkeys","volume":"22","author":"de","year":"1994","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jfo.2011.10.002_bib0550","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1136\/bjo.70.6.435","article-title":"Oral acyclovir (Zovirax) in herpes simplex dendritic corneal ulceration","volume":"70","author":"Collum","year":"1986","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0555","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1001\/archopht.118.8.1030","article-title":"Oral acyclovir for herpes simplex virus eye disease: effect on prevention of epithelial keratitis and stromal keratitis","volume":"118","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0560","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1128\/AAC.00615-10","article-title":"Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management","volume":"55","author":"Piret","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jfo.2011.10.002_bib0565","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S1386-6532(03)00164-1","article-title":"Once, twice, or three times daily famciclovir compared with aciclovir for the oral treatment of herpes zoster in immunocompetent adults: a randomized, multicenter, double-blind clinical trial","volume":"29","author":"Shafran","year":"2004","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0570","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ajo.2009.02.010","article-title":"Vitreous penetration of orally administered famciclovir","volume":"148","author":"Chong","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0575","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1001\/archopht.1984.01040031462023","article-title":"Prophylactic topical cyclosporine in experimental herpetic stromal keratitis","volume":"102","author":"Boisjoly","year":"1984","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0580","first-page":"494","article-title":"Suppression of secondary herpes simplex uveitis by cyclosporine","volume":"26","author":"Oh","year":"1985","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2011.10.002_bib0585","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s004170050257","article-title":"Treatment of HSV-1\u00a0stromal keratitis with topical cyclosporin A: a pilot study","volume":"237","author":"Heiligenhaus","year":"1999","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0590","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ajo.2005.11.042","article-title":"Treatment of herpes simplex virus stromal keratitis unresponsive to topical prednisolone 1\u00a0% with topical cyclosporine 0.05\u00a0%","volume":"141","author":"Rao","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0595","doi-asserted-by":"crossref","first-page":"832","DOI":"10.3928\/1542-8877-19981001-09","article-title":"Photodynamic therapy for corneal neovascularization","volume":"29","author":"Primbs","year":"1998","journal-title":"Ophthalmic Surg Lasers"},{"key":"10.1016\/j.jfo.2011.10.002_bib0600","doi-asserted-by":"crossref","first-page":"9828","DOI":"10.1128\/JVI.75.20.9828-9835.2001","article-title":"Contribution of vascular endothelial growth factor in the neovascularization process during the pathogenesis of herpetic stromal keratitis","volume":"75","author":"Zheng","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0605","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00705-008-0303-7","article-title":"HSV immune complex (HSV-IgG: IC) and HSV-DNA elicit the production of angiogenic factor VEGF and MMP-9","volume":"154","author":"Hayashi","year":"2009","journal-title":"Arch Virol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0610","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/08820530802111408","article-title":"Who (what) pays toll for the development of herpetic stromal keratitis (HSK)","volume":"23","author":"Hayashi","year":"2008","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0615","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1084\/jem.20091385","article-title":"VEGF-A expression by HSV-1-infected cells drives corneal lymphangiogenesis","volume":"207","author":"Wuest","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.jfo.2011.10.002_bib0620","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.exer.2005.05.001","article-title":"Involvement of IL-6\u00a0in the paracrine production of VEGF in ocular HSV-1\u00a0infection","volume":"82","author":"Biswas","year":"2006","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jfo.2011.10.002_bib0625","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00417-009-1101-y","article-title":"Anti-VEGF monoclonal antibody-induced regression of corneal neovascularization and inflammation in a rabbit model of herpetic stromal keratitis","volume":"247","author":"Saravia","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0630","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/S0002-9440(10)63267-1","article-title":"Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis","volume":"165","author":"Kim","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0635","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.mehy.2007.01.032","article-title":"Therapeutic potential of bevacizumab (Avastin) in herpetic stromal keratitis (HSK)","volume":"69","author":"Hosseini","year":"2007","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.jfo.2011.10.002_bib0640","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.ophtha.2009.04.016","article-title":"GS-101\u00a0antisense oligonucleotide eye drops inhibit corneal neovascularization: interim results of a randomized phase II trial","volume":"116","author":"Cursiefen","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2011.10.002_bib0645","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1097\/ICO.0b013e3181a2a7f6","article-title":"Autologous serum 50\u00a0% eyedrops in the treatment of persistent corneal epithelial defects","volume":"28","author":"Jeng","year":"2009","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2011.10.002_bib0650","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1442-9071.2008.01680.x","article-title":"Autologous serum in the management of recalcitrant dry eye syndrome","volume":"36","author":"Lee","year":"2008","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0655","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ajo.2004.08.040","article-title":"The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case-control study","volume":"139","author":"Kojima","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0660","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0181-5512(04)96139-6","article-title":"Traitement du syndrome sec grave par s\u00e9rum autologue","volume":"27","author":"Creuzot-Garcher","year":"2004","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0665","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/S0161-6420(99)90412-8","article-title":"Treatment of persistent corneal epithelial defect by autologous serum application","volume":"106","author":"Tsubota","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2011.10.002_bib0670","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1136\/bjo.84.8.826","article-title":"Amniotic membrane transplantation for severe neurotrophic corneal ulcers","volume":"84","author":"Chen","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0675","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/S0161-6420(99)90444-X","article-title":"Multilayer amniotic membrane transplantation for reconstruction of deep corneal ulcers","volume":"106","author":"Kruse","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2011.10.002_bib0680","first-page":"798","article-title":"[Amniotic membrane graft in ocular surface disease. Prospective study with 31\u00a0cases.] La greffe de membrane amniotique dans les pathologies oculaires de surface","volume":"24","author":"Muraine","year":"2001","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0685","first-page":"1969","article-title":"Improvement of HSV-1\u00a0necrotizing keratitis with amniotic membrane transplantation","volume":"42","author":"Heiligenhaus","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2011.10.002_bib0690","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.ophtha.2006.11.027","article-title":"Amniotic membrane transplantation combined with antiviral and steroid therapy for herpes necrotizing stromal keratitis","volume":"114","author":"Shi","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2011.10.002_bib0695","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1167\/iovs.08-3041","article-title":"Amniotic membrane transplantation induces apoptosis in T lymphocytes in murine corneas with experimental herpetic stromal keratitis","volume":"50","author":"Bauer","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2011.10.002_bib0700","first-page":"21","article-title":"Therapeutic effect of amniotic membrane in persistent epithelial defects and corneal ulcers in herpetic keratitis","volume":"32","author":"Brijacak","year":"2008","journal-title":"Coll Antropol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0705","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1097\/00003226-200110000-00010","article-title":"Amniotic membrane transplantation in infectious corneal ulcer","volume":"20","author":"Kim","year":"2001","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2011.10.002_bib0710","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1350-9462(99)00004-X","article-title":"Treatment of viral diseases of the cornea and external eye","volume":"19","author":"Kaufman","year":"2000","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.jfo.2011.10.002_bib0715","series-title":"Les infections oculaires","first-page":"164","article-title":"K\u00e9ratites \u00e0 HSV","author":"Labetoulle","year":"2010"},{"key":"10.1016\/j.jfo.2011.10.002_bib0720","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/S0161-6420(94)31087-6","article-title":"Herpetic eye disease study. A controlled trial of topical corticosteroids for herpes simplex stromal keratitis","volume":"101","author":"Wilhelmus","year":"1994","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2011.10.002_bib0725","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1136\/bjo.74.5.283","article-title":"A comparison of local and systemic acyclovir in the management of herpetic disciform keratitis","volume":"74","author":"Porter","year":"1990","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0730","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.survophthal.2009.02.002","article-title":"Topical ophthalmic cyclosporine: pharmacology and clinical uses","volume":"54","author":"Donnenfeld","year":"2009","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0735","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1442-9071.1996.tb01567.x","article-title":"Evaluation of topical 0.03\u00a0% flurbiprofen drops in the treatment of herpetic stromal keratitis","volume":"24","author":"Vajpayee","year":"1996","journal-title":"Aust N Z J Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0740","article-title":"Herpetic epithelial keratitis after intravitreal injection of bevacizumab (Avastin)","author":"Khalili","year":"2010","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2011.10.002_bib0745","doi-asserted-by":"crossref","DOI":"10.1007\/s00417-009-1170-y","article-title":"Avastin use in high risk corneal transplantation","author":"Vassileva","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0750","first-page":"343","article-title":"Role of the corneal nerves in destructive disease of the cornea","volume":"98","author":"Mackie","year":"1978","journal-title":"Trans Ophthalmol Soc UK"},{"key":"10.1016\/j.jfo.2011.10.002_bib0755","first-page":"1063","article-title":"Nerve growth factor promotes corneal healing: structural, biochemical, and molecular analyses of rat and human corneas","volume":"41","author":"Lambiase","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2011.10.002_bib0760","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/01.ico.0000176609.42838.df","article-title":"Use of nerve growth factor to treat congenital neurotrophic corneal ulceration","volume":"25","author":"Tan","year":"2006","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2011.10.002_bib0765","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/1752-1947-1-124","article-title":"The use of nerve growth factor in herpetic keratitis: a case report","volume":"1","author":"Mauro","year":"2007","journal-title":"J Med Case Reports"},{"key":"10.1016\/j.jfo.2011.10.002_bib0770","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00417-007-0593-6","article-title":"Topical treatment with nerve growth factor in an animal model of herpetic keratitis","volume":"246","author":"Lambiase","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0775","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0161-6420(00)00163-9","article-title":"Topical treatment with nerve growth factor for neurotrophic keratitis","volume":"107","author":"Bonini","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2011.10.002_bib0780","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3109\/13550289709018295","article-title":"Nerve growth factor antibody stimulates reactivation of ocular herpes simplex virus type 1\u00a0in latently infected rabbits","volume":"3","author":"Hill","year":"1997","journal-title":"J Neurovirol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0785","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000310447","article-title":"Epidermal growth factor in the topical treatment of herpetic corneal ulcers","volume":"208","author":"Cellini","year":"1994","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.jfo.2011.10.002_bib0790","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/BF00165937","article-title":"Treatment of persistent epithelial defects in neurotrophic keratitis with epidermal growth factor: a preliminary open study","volume":"230","author":"Daniele","year":"1992","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0795","series-title":"L\u2019herp\u00e8s et le zona oculaire en pratique\u00a0: clinique, th\u00e9rapeutique et pr\u00e9vention\u201d","first-page":"145","article-title":"R\u00e9habilitation visuelle chirurgicale apr\u00e8s k\u00e9ratite herp\u00e9tique","author":"Muraine","year":"2009"},{"key":"10.1016\/j.jfo.2011.10.002_bib0800","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jfo.2009.01.008","article-title":"An update on the use of tissue adhesives in ophthalmology","volume":"32","author":"Vera","year":"2009","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0805","doi-asserted-by":"crossref","first-page":"4703","DOI":"10.1167\/iovs.09-4884","article-title":"Effect of high versus low oral doses of valacyclovir on herpes simplex virus-1\u00a0DNA shedding into tears of latently infected rabbits","volume":"51","author":"Kumar","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2011.10.002_bib0810","first-page":"6","article-title":"Traitement pr\u00e9ventif des k\u00e9ratites herp\u00e9tiques par l\u2019acyclovir en comprim\u00e9s","volume":"16","author":"Colin","year":"1993","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0815","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0161-6420(96)30492-2","article-title":"Long-term oral acyclovir therapy. Effect on recurrent infectious herpes simplex keratitis in patients with and without grafts","volume":"103","author":"Simon","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2011.10.002_bib0820","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/archopht.117.3.391","article-title":"Oral acyclovir suppresses recurrent epithelial and stromal herpes simplex","volume":"117","author":"Langston","year":"1999","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0825","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/BF01268121","article-title":"Recurrence rate of herpetic uveitis in patients on long-term oral acyclovir","volume":"90","author":"Rodriguez","year":"1995","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0830","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1128\/JCM.42.1.242-249.2004","article-title":"Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up","volume":"42","author":"Danve-Szatanek","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0835","first-page":"1569","article-title":"Acyclovir for the treatment and prevention of recurrent infectious herpes simplex keratitis","volume":"115","author":"Wu","year":"2002","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.jfo.2011.10.002_bib0840","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1001\/archopht.121.12.1702","article-title":"Long-term acyclovir use to prevent recurrent ocular herpes simplex virus infection","volume":"121","author":"Uchoa","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0845","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archopht.117.4.445","article-title":"Oral acyclovir after penetrating keratoplasty for herpes simplex keratitis","volume":"117","author":"Tambasco","year":"1999","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0850","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/S0161-6420(03)00798-X","article-title":"Effect of oral acyclovir after penetrating keratoplasty for herpetic keratitis: a placebo-controlled multicenter trial","volume":"110","author":"vanRooij","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2011.10.002_bib0855","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1097\/ICO.0b013e318198399a","article-title":"Five-year follow-up on the effect of oral acyclovir after penetrating keratoplasty for herpetic keratitis","volume":"28","author":"Jansen","year":"2009","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2011.10.002_bib0860","first-page":"285","article-title":"Valacyclovir for the prevention of recurrent herpes simplex virus eye disease after excimer laser photokeratectomy","volume":"98","author":"Asbell","year":"2000","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.jfo.2011.10.002_bib0865","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/j.jcrs.2007.07.014","article-title":"Laser in situ keratomileusis in patients with a history of ocular herpes","volume":"33","author":"de Rojas Silva","year":"2007","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.jfo.2011.10.002_bib0870","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S0886-3350(01)00804-5","article-title":"Valacyclovir inhibition of recovery of ocular herpes simplex virus type 1\u00a0after experimental reactivation by laser in situ keratomileusis","volume":"27","author":"Dhaliwal","year":"2001","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.jfo.2011.10.002_bib0875","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/ICO.0b013e318182262c","article-title":"New-onset herpes simplex virus keratitis after cataract surgery","volume":"28","author":"Patel","year":"2009","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2011.10.002_bib0880","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ajo.2007.10.005","article-title":"Acyclovir therapy in prevention of recurrent herpetic keratitis following penetrating keratoplasty","volume":"145","author":"Ghosh","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2011.10.002_bib0885","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/mt.2010.302","article-title":"Meganuclease-mediated Inhibition of HSV1\u00a0Infection in Cultured Cells","volume":"19","author":"Grosse","year":"2011","journal-title":"Mol Ther"},{"key":"10.1016\/j.jfo.2011.10.002_bib0890","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.4161\/hv.6.12.13347","article-title":"Herpesvirus vaccines: Challenges and future prospects","volume":"6","author":"Smith","year":"2010","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.jfo.2011.10.002_bib0895","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1080\/02713680500313153","article-title":"Prospects for developing an effective vaccine against ocular herpes simplex virus infection","volume":"30","author":"Koelle","year":"2005","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.jfo.2011.10.002_bib0900","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/S0264-410X(98)00434-4","article-title":"Herpes simplex virus vaccines","volume":"17","author":"Bernstein","year":"1999","journal-title":"Vaccine"}],"container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551212000265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551212000265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:02:54Z","timestamp":1759258974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0181551212000265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":180,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0181551212000265"],"URL":"https:\/\/doi.org\/10.1016\/j.jfo.2011.10.002","relation":{},"ISSN":["0181-5512"],"issn-type":[{"type":"print","value":"0181-5512"}],"subject":[],"published":{"date-parts":[[2012,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aspects actuels du traitement des k\u00e9ratites herp\u00e9tiques","name":"articletitle","label":"Article Title"},{"value":"Journal Fran\u00e7ais d'Ophtalmologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfo.2011.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}